As this is a retrospective study that included patients treated over a long time period, limitations of the study include the lack of O6-methylguanine–DNA methyltransferase (MGMT) methylation status and IDH-1 mutation status for only a portion of tumours. The gene discussed is MGMT; the disease is neoplasm.